Search results
Signs and Symptoms of Tardive Dyskinesia
Health via Yahoo News· 6 months agoTardive dyskinesia is a movement disorder that affects the nervous system, causing symptoms like abnormal and involuntary movements in the face, limbs,...
What Is Tardive Dyskinesia?
Health via Yahoo News· 12 months agoTardive dyskinesia (TD) is a medication-induced neurological condition, meaning it affects the brain and nervous system. TD is caused by the use of...
Does Neurocrine, The No. 1 Biotech Stock, Have The Next Ketamine On Its Hands?
Investor's Business Daily· 2 hours agoTop-notch biotech stock Neurocrine Biosciences surged Tuesday after analysts suggested the company's...
The $1 Billion Opportunity Driving IBD Stock Of The Day Neurocrine Higher
Investor's Business Daily· 1 month agoNeurocrine Biosciences is Monday's IBD Stock Of The Day. Milestones are stacking up in 2024 and...
Blazing Hot Neurocrine Biosciences, With 40% Run This Year, Extends Breakout On Quarterly Beat
Investor's Business Daily· 1 year agoNeurocrine Biosciences handily beat Wall Street's third-quarter expectations Tuesday, leading NBIX...
Neurocrine Reports 3,000% Profit Growth, But Shares Unexpectedly Tumble
Investor's Business Daily· 1 year agoNeurocrine Biosciences reported soaring fourth-quarter profit Monday and issued in-line guidance for...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 5 days agoBiotech stocks have been on a roller-coaster ride, but have started to fade in 2024. In 2020, the...
The Make-Or-Break Moment Is Here For Highly Rated Neurocrine Biosciences
Investor's Business Daily· 2 years agoWall Street says it's make-or-break time for Neurocrine Biosciences' essential tremors treatment, as...
Teva Pharmaceutical: Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 5 months agoTeva Pharmaceutical Industries (NYSE:TEVA) is one of the leading companies in the healthcare sector, specializing in developing and commercializing...
Teva, GSK Put Up Bullish Fourth-Quarter Performances. Here's Where Novartis Fell Short.
Investor's Business Daily· 3 months agoTeva stock neared a profit-taking zone Wednesday, while GSK stock — a fellow pharma Goliath —...
